Skip to content

DELTAPAQ DFS100154-20Recalls & reported problems

Medos International Sàrl · DELTAPAQ microcoil DELTAPAQ 10 Stretch Resistant Coil 1.5mm x 4cm 190cm Contents: 1 Detachable Coil System · Class 2 · Implant

All models of DELTAPAQ (18)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00878528007531), received between Feb 26, 2019 and Feb 26, 2019 — classified as 1 malfunction.

The most frequently reported specific device problem is “Material Deformation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Material Deformation1
  • Material Separation1
  • Stretched1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 26, 2019Material Separation; Stretched; Material Deformation; Material Separation; Stretched; Material Deformation

    A REPORT WAS RECEIVED THAT THE 1.5MM X 4CM DELTAPAQ (DFS10015420/P11766) MICROCOIL PROTRUDED FROM THE GREEN INTRODUCER WHILE ADVANCING THE DEVICE POSITIONING UNIT (DPU) WIRE THROUGH THE INTRODUCER SHEATH. NO PATIENT COMPLICATIONS OCCURRED AS A RESULT OF THE EVENT. EVALUATION OF THE RETURNED DEVICE REVEALED SIGNIFICANT EMBOLIC COIL DAMAGE. NO FURTHER INFORMATION WAS PROVIDED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 8372507 ↗

Other DEVICE, NEUROVASCULAR EMBOLIZATION devices

All DEVICE, NEUROVASCULAR EMBOLIZATION devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page